Acceptance and Reasons for Teleconsultation in Gynecology (telecs-gyneco)

February 13, 2026 updated by: Université de Reims Champagne-Ardenne

Telemedicine is a form of remote medical practice using information and communication technologies. Teleconsultation is the most common form of telemedicine, thanks in particular to improvements in connectivity and the development and widespread use of mobile phones. It has become a hot topic since the COVID-19 epidemic in 2020, although it has been around since 2009. Patients highlight the convenience, time and cost savings, and positive environmental impact. However, they also point out the limitations associated with a lack of technical expertise in the platforms used, confidentiality issues and more limited access for people from low socio-economic backgrounds or without a good internet connection.

Gynecology is an important part of the work of midwives, gynecologists and general practitioners. In this respect, it was essential to maintain consultations during the pandemic. In this context, it seems important to assess the acceptability of teleconsultation in gynecology and to identify the most appropriate reasons for consultation.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The Main Objective is to describe women's acceptance of teleconsultation in gynecology

Study Type

Observational

Enrollment (Actual)

343

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Reims, France, 51100
        • Ufr Medecine Urca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

women aged 18 and over, who may or may not have already used teleconsultation (for gynecological or other reasons), and who may or may not have already had a gynecological consultation, who agreed to take part in the study.

Description

Inclusion Criteria:

  • Women Aged 18 and over
  • Whether or not they have already had a teleconsultation, whether in gynaecology or another medical speciality
  • Whether or not they had already had a gynaecology consultation
  • Agreed to take part in the study

Exclusion Criteria:

  • Minors
  • Not willing to take part in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire to assess the acceptance of gynecological teleconsultation
Time Frame: Day 0
The acceptability of gynecological teleconsultation will be assessed using a specific questionnaire developed for this study including questions related to the perception of this mode of consultation in gynecology and its acceptance or non-acceptance by the participants
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Université de Reims Champagne-Ardenne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 19, 2024

Primary Completion (Actual)

April 18, 2025

Study Completion (Actual)

July 31, 2025

Study Registration Dates

First Submitted

February 6, 2026

First Submitted That Met QC Criteria

February 13, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 13, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2024_RIPH_12_telecs-gyneco

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gynecology

Clinical Trials on Data colllection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe